|
|
| Research article summary (published 28 Feb 2004): |
Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
Full Abstract
Attention-deficit hyperactivity disorder (ADHD) is a common condition during childhood that is associated with significant psychosocial dysfunction. Psychostimulants are the compounds that have been most extensively studied for the treatment of ADHD in children. There is substantial scientific evidence that several methylphenidate- and amphetamine-based preparations have acute efficacy in the treatment of this condition in children. The short-term safety and tolerability of these compounds has been reasonably well-studied and the risks associated with psychostimulant therapy in the short-term are generally acceptable. However, the amount of long-term effectiveness and safety data relating to these compounds is relatively small. Data that do exist suggest that long-term treatment with psychostimulants in appropriately diagnosed patients may be associated with salutary effects as well as relatively modest risks. Until more extensive, methodologically rigorous data are available, it appears that judicious psychostimulant pharmacotherapy of ADHD in children may be justified.
Author information
Author/s: Kociancic, Todd (T); Reed, Michael D (MD); Findling, Robert L (RL);
Affiliation: Department of Psychiatry, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Grants: HD-31324-09 (Agency:NICHD NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
Journal: Expert opinion on drug safety (Expert Opin Drug Saf), published in England. (Language: eng)
Reference: 2004-Mar; vol 3 (issue 2) : pp 93-100
Dates: Created 2004/03/09; Completed 2004/05/10; Revised 2007/11/14;
PMID: 15006715, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: 18 Feb 2009 00:00:00)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
26 Oct 2005 - An update on attention deficit disorder.
29 Apr 2004 - Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence.
30 Dec 2003 - Treatment of attention-deficit-hyperactivity disorder.
9 Mar 1999 - Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
30 Dec 1990 - Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
30 Mar 1999 - Psychostimulants in supportive care.
30 Aug 2000 - Gilles de la Tourette's syndrome: effects of stimulant drugs.
30 Aug 1985 - Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
30 Mar 2008 - Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.
29 Sep 1997
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.